---
title: "Radiopharmaceutical Injection Equipment"
ocid: "ocds-r6ebe6-0000766791"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000766791"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000766791.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000766791.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "NHS GREATER GLASGOW AND CLYDE"
published: "2024-06-04"
---

# Radiopharmaceutical Injection Equipment

Buyer: NHS GREATER GLASGOW AND CLYDE  
Current stage: Award  
OCID: ocds-r6ebe6-0000766791

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000766791)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000766791.json)

## Summary

The procurement for Radiopharmaceutical Injection Equipment was awarded by NHS Greater Glasgow and Clyde with a contract value of £248,092.23. The tender was at the award stage on 15th May 2024. The procurement method used was a limited Award procedure without prior publication of a call for competition. The equipment was for the Health industry category, specifically for administering therapeutic radiopharmaceuticals, with key features such as approval for multiple pharmaceuticals and vials swapping capability. The location for the procurement was in Glasgow, UK.

This procurement opportunity for Radiopharmaceutical Injection Equipment presented by NHS Greater Glasgow and Clyde could be beneficial for large businesses in the Health sector specialising in medical equipment supply. The contract involves a significant financial investment aimed at enhancing cancer treatment services. Businesses with expertise in Shielded Radiopharmaceutical Injector production and maintenance services, compliant with CE/UKCA regulations, are well-positioned to compete. The procurement method being a limited procedure without prior publication implies a narrow selection of potential suppliers due to technical constraints, providing a strategic advantage for companies offering unique, compliant solutions.

## Notice

NHS Greater Glasgow & Clyde require a Shielded Radiopharmaceutical Injector to administer therapeutic radiopharmaceuticals for patients undergoing molecular radiation therapy as part of their cancer treatment, with 156,485.00 GBP charitable money allocated to this purchase. Furthermore, an allocation of 91,607.23 GBP has been assigned for the maintenance of this unit, which includes 2 years' worth of warranty and 6 years of maintenance support including Servicing, Breakdown labour and parts, and Remote support. Market engagement suggests no alternative solution for this requirement, due to the below:- The system must be approved (CE/UKCA) for use with both Lu-177 and I-131 pharmaceuticals, which are the two therapeutic radionuclides the department expect to use the injector for. It should be possible to swap out vials to allow multi-vial administrations. Through market engagement the equipment is considered the solitary option for the Health Boards requirement. In order to award this contract compliantly, NHSGGC will follow Regulation 32 of the Public Contracts (Scotland) Regulations: (2) (b) (ii) where the works, supplies or services can be supplied only by a particular economic operator for any of the following reasons (ii)competition is absent for technical reasons

### Procurement Information

In order to award this contract compliantly, NHSGGC will follow Regulation 32 of the Public Contracts (Scotland) Regulations: (2) (b) (ii) where the works, supplies or services can be supplied only by a particular economic operator for any of the following reasons (ii)competition is absent for technical reasons Market engagement suggests no alternative solution for this requirement, due to the below:- The system must be approved (CE/UKCA) for use with both Lu-177 and I-131 pharmaceuticals, which are the two therapeutic radionuclides the department expect to use the injector for. It should be possible to swap out vials to allow multi-vial administrations. Through market engagement the equipment is considered the solitary option for the Health Boards requirement.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN506573 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 4 Jun 2024 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 15 May 2024 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £248,092 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS GREATER GLASGOW AND CLYDE |
| Locality | GLASGOW |
| Post town | Glasgow |
| Postcode | G4 0SF |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM3 West Central Scotland |
| ITL 3 | TLM32 Glasgow City |
| Local authority | Glasgow City |
| Electoral ward | Dennistoun |
| Westminster constituency | Glasgow North East |
| Delivery location | TLM82 Glasgow City |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | SOUTHERN SCIENTIFIC |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33000000 - Medical equipments, pharmaceuticals and personal care products

## Release History

- 4 Jun 2024 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN506573
- 15 May 2024 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY505349

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY505349
  Radiopharmaceutical Injection Equipment - NHS Greater Glasgow & Clyde require a Shielded Radiopharmaceutical Injector to administer therapeutic radiopharmaceuticals for patients undergoing molecular radiation therapy as part of their cancer treatment, with 156,485.00 GBP charitable money allocated to this purchase. Furthermore, an allocation of 91,607.23 GBP has been assigned for the maintenance of this unit, which includes 2 years' worth of warranty and 6 years of maintenance support including Servicing, Breakdown labour and parts, and Remote support. Market engagement suggests no alternative solution for this requirement, due to the below:- The system must be approved (CE/UKCA) for use with both Lu-177 and I-131 pharmaceuticals, which are the two therapeutic radionuclides the department expect to use the injector for. It should be possible to swap out vials to allow multi-vial administrations. Through market engagement the equipment is considered the solitary option for the Health Boards requirement. In order to award this contract compliantly, NHSGGC will follow Regulation 32 of the Public Contracts (Scotland) Regulations: (2) (b) (ii) where the works, supplies or services can be supplied only by a particular economic operator for any of the following reasons (ii)competition is absent for technical reasons
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN506573
  Radiopharmaceutical Injection Equipment - NHS Greater Glasgow & Clyde require a Shielded Radiopharmaceutical Injector to administer therapeutic radiopharmaceuticals for patients undergoing molecular radiation therapy as part of their cancer treatment, with 156,485.00 GBP charitable money allocated to this purchase. Furthermore, an allocation of 91,607.23 GBP has been assigned for the maintenance of this unit, which includes 2 years' worth of warranty and 6 years of maintenance support including Servicing, Breakdown labour and parts, and Remote support. Market engagement suggests no alternative solution for this requirement, due to the below:- The system must be approved (CE/UKCA) for use with both Lu-177 and I-131 pharmaceuticals, which are the two therapeutic radionuclides the department expect to use the injector for. It should be possible to swap out vials to allow multi-vial administrations. Through market engagement the equipment is considered the solitary option for the Health Boards requirement. In order to award this contract compliantly, NHSGGC will follow Regulation 32 of the Public Contracts (Scotland) Regulations: (2) (b) (ii) where the works, supplies or services can be supplied only by a particular economic operator for any of the following reasons (ii)competition is absent for technical reasons

## Notice URLs

- http://
- http://www.nhsggc.scot/about-us/procurement/
- http://www.scotcourts.gov.uk
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000766791

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000766791. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000766791.json.